ExpressionEdits

By strategically incorporating multiple short noncoding DNA sequences known as introns into artificial genes, ExpressionEdits has achieved significant enhancements in gene expression which leads to better protein production.

The company’s AI-powered platform integrates millions of biological data points with machine learning algorithms, enabling automated optimisation of gene design. European VC firms Octopus Ventures and redalpine co-led ExpressionEdits’ $13m seed funding round in May 2024.